Business
NanoEcho PoC Study Does Not Meet Primary Endpoint
NanoEcho PoC Study Does Not Meet Primary Endpoint
About this update from Nanoecho Ab
NanoEcho AB (publ) OMXSTO:NANECH:ANNOUNCES RESULTS FROM INITIAL PART OF EXPLORATORY PROOF OF CONCEPT (POC) STUDY IN HEALTHY STUDY PARTICIPANTSSTUDY DID NOT ACHIEVE PRIMARY ENDPOINTPRIMARY ENDPOINT WAS TO VALIDATE PREVIOUSLY ESTABLISHED DOSE OF NANOPARTICLE NEP-01, TIMING OF EXAMINATION WITH CO'S DIAGNOSTIC SYSTEMNO SERIOUS ADVERSE EFFECTS HAVE BEEN REPORTED DURING STUDYBASED ON RESULTS, CO TO EVALUATE WHETHER ANY ADJUSTMENTS TO DIAGNOSTIC SYSTEM, METHOD MAY BE RELEVANT FOR NEXT PART OF POC STUDY